News 2 Nov 2026 Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
Press releases 29 Oct 2026 DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai
Scientific articles 27 Oct 2026 Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022) Frontiers in Tropical Diseases
Scientific articles 26 Oct 2026 Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial eClinicalMedicine
Scientific articles 22 Oct 2026 Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis Nature communications
Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infectious Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
Press releases 15 Jun 2016 Celgene joins DNDi’s ‘Drug Discovery Booster’ to accelerate discovery of new treatments for neglected diseases
Press releases 8 Jun 2016 DNDi, Mundo Sano and Chemo team up to register benznidazole in US and Latin America
Press releases 1 Jun 2016 DNDi response to Government of Japan replenishment of The Global Health Innovative Technology Fund
Press releases 24 May 2016 Global Antibiotic Research & Development Partnership (GARDP) garners key financial support for launch
Press releases 13 Apr 2016 Drugs for Neglected Diseases initiative and Pharco Pharmaceuticals to test affordable hepatitis C regimen with support of Malaysian and Thai governments
Press releases 13 Jan 2016 Clinical Research Malaysia and the Drugs for Neglected Diseases initiative sign agreement to launch clinical studies for a public health approach to hepatitis C in Malaysia
Press releases 14 Dec 2015 DNDi statement on KaloBios’ intention to raise price of Chagas drug and file for FDA priority review
Press releases 30 Nov 2015 World AIDS Day 2015: Study begins in Kenya for recently-approved paediatric HIV treatment
Press releases 16 Oct 2015 Drugs for Neglected Diseases initiative unveils new plan for neglected patients at a key gathering of experts in India
Press releases 8 Oct 2015 French Development Agency AFD and DNDi sign partnership agreement for control of leishmaniasis in East Africa
Press releases 6 Oct 2015 DNDi awarded USD 2.34 million from new pooled fund mechanism at WHO-TDR in support of global leishmaniasis R&D demonstration project
Press releases 5 Oct 2015 DNDi applauds 2015 Nobel Prize winners for key advancements in fighting malaria, river blindness, and lymphatic filariasis
Press releases 10 Sep 2015 Drugs for Neglected Diseases initiative and Eisai Co., Ltd. to test drug candidate for Eumycetoma
Press releases 8 Sep 2015 Pivotal clinical trial to begin for first oral drug candidate specifically developed for sleeping sickness
Press releases 7 Sep 2015 Drugs for Neglected Diseases initiative unveils new plan for neglected patients
